| High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality A Capone, M Giannella, D Fortini, A Giordano, M Meledandri, M Ballardini, ... Clinical Microbiology and Infection 19 (1), E23-E30, 2013 | 393 | 2013 |
| Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects S Di Bella, P Ascenzi, S Siarakas, N Petrosillo, A Di Masi Toxins 8 (5), 134, 2016 | 290 | 2016 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 256 | 2022 |
| Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention S Biffi, S Di Bella, V Scaravilli, AM Peri, G Grasselli, L Alagna, A Pesenti, ... International journal of antimicrobial agents 50 (1), 9-16, 2017 | 199 | 2017 |
| WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections M Sartelli, F Coccolini, Y Kluger, E Agastra, FM Abu-Zidan, AES Abbas, ... World journal of emergency surgery 16, 1-48, 2021 | 165 | 2021 |
| 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients M Sartelli, S Di Bella, LV McFarland, S Khanna, L Furuya-Kanamori, ... World Journal of Emergency Surgery 14, 1-29, 2019 | 164 | 2019 |
| Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study DR Giacobbe, D Battaglini, EM Enrile, C Dentone, A Vena, C Robba, ... Journal of clinical medicine 10 (4), 555, 2021 | 132 | 2021 |
| Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients’ outcome G Grasselli, V Scaravilli, S Di Bella, S Biffi, M Bombino, N Patroniti, L Bisi, ... Critical care medicine 45 (10), 1726-1733, 2017 | 132 | 2017 |
| WSES guidelines for management of Clostridium difficile infection in surgical patients M Sartelli, MA Malangoni, FM Abu-Zidan, EA Griffiths, S Di Bella, ... World Journal of Emergency Surgery 10, 1-23, 2015 | 124 | 2015 |
| Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment N Riccardi, RM Antonello, R Luzzati, J Zajkowska, S Di Bella, ... European journal of internal medicine 62, 1-6, 2019 | 123 | 2019 |
| The revival of aztreonam in combination with avibactam against metallo-β-lactamase-producing Gram-negatives: a systematic review of in vitro studies and clinical cases C Mauri, AE Maraolo, S Di Bella, F Luzzaro, L Principe Antibiotics 10 (8), 1012, 2021 | 103 | 2021 |
| Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients S Di Bella, T Gouliouris, N Petrosillo Journal of Infection and Chemotherapy 21 (4), 230-237, 2015 | 99 | 2015 |
| Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens J Monticelli, A Knezevich, R Luzzati, S Di Bella Journal of Infection and Chemotherapy 24 (4), 237-246, 2018 | 95 | 2018 |
| Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies S Di Bella, DR Giacobbe, AE Maraolo, V Viaggi, R Luzzati, M Bassetti, ... Journal of Global Antimicrobial Resistance 25, 268-281, 2021 | 83 | 2021 |
| Profiling of oral microbiota and cytokines in COVID-19 patients V Iebba, N Zanotta, G Campisciano, V Zerbato, S Di Bella, C Cason, ... Frontiers in Microbiology 12, 671813, 2021 | 67 | 2021 |
| History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies S Di Bella, N Riccardi, DR Giacobbe, R Luzzati Pathogens and global health 112 (5), 268-273, 2018 | 67 | 2018 |
| Dengue: Status of current and under‐development vaccines M Redoni, S Yacoub, L Rivino, DR Giacobbe, R Luzzati, S Di Bella Reviews in medical virology 30 (4), e2101, 2020 | 66 | 2020 |
| Measles: an overview of a re-emerging disease in children and immunocompromised patients A Misin, RM Antonello, S Di Bella, G Campisciano, N Zanotta, ... Microorganisms 8 (2), 276, 2020 | 65 | 2020 |
| Human Serum Albumin Is an Essential Component of the Host Defense Mechanism Against Clostridium difficile Intoxication A Di Masi, L Leboffe, F Polticelli, F Tonon, C Zennaro, M Caterino, ... The Journal of infectious diseases 218 (9), 1424-1435, 2018 | 62 | 2018 |
| The novel influenza A (H1N1) virus pandemic: An update N Petrosillo, S Di Bella, CM Drapeau, E Grilli Annals of Thoracic Medicine 4 (4), 163-172, 2009 | 60 | 2009 |
Verena ZerbatoMedico in formazione specialistica in Malattie Infettive e Tropicali, Università degli Studi di Udine, in formazione presso la SC di Malattie Infettive di Trieste (ASUGI)Verified email at asugi.sanita.fvg.it
